As of 9:55 am, Global Health Limited (Medanta) shares were trading 1.96% higher at ₹1,095.15 on the NSE, following the announcement of a new 750-bed super-speciality hospital in New Delhi. This expansion is a major step for Medanta as it seeks to enhance healthcare infrastructure in India by providing specialized medical care across disciplines like cardiology, neurology, oncology, and orthopedics.
Medanta has allocated around ₹600 crore to support this venture, with plans to invest over the next three to four years in building state-of-the-art infrastructure and acquiring advanced medical technology. The project aligns with Medanta’s reputation for quality care and is expected to establish a facility that will serve a significant patient base in Delhi and surrounding regions.
Dr. Naresh Trehan, Chairman and Managing Director of Global Health Limited, emphasized that this facility aims to make high-quality healthcare more accessible. This initiative represents an important milestone in Medanta’s journey to expand its reach and bring comprehensive healthcare services closer to communities.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. The author or Business Upturn is not liable for any losses arising from the use of this information.
